Abstract:The objective of this study was to evaluate the in vivo application and photothermal ablation effects and mechanism of copper sulfide nanoparticles (CuS NPs) in hepatocellular carcinoma (HCC). Sheet-like CuS-BSA NPs with a particle size of 30 nm were synthesized using bovine serum albumin (BSA) as a biological modifier, and were physically characterized. To provide a reference range for the biosafety dose of CuS-BSA NPs, 36 male Kunming mice were randomly assigned into six groups. Different one-time doses of CuS-BSA NPs were injected via tail vein injection, and the potential damages of liver, kidney and spleen were observed 14 days later. To evaluate the in vivo photothermal effect of CuS-BSA NPs, 48 male Kunming mice were used to establish the H22 hepatoma-bearing mouse model and were randomly assigned into six groups. CuS-BSA NPs (600 μg/kg) were injected via tail vein or intratumoral injection. Irradiations were performed 30 min after injection, with a 980 nm near-infrared laser (2.0 W/cm 2 ) for 10 min once a week for 3 weeks. The results indicated that the CuS-BSA NPs had good dispersibility in three different solvents and had a strong absorption peak at 980 nm. The heating curves demonstrated that the photothermal effects of CuS-BSA NPs aqueous solution exhibited concentration dependence and power density dependence. In the in vivo experiment, when the doses of CuS-BSA NPs were in the range of 1800–7,200 μg/kg, the thymus index and spleen index of mice were not significantly different from those of the control group, and the structures of liver, kidney and spleen were intact without remarkable pathological changes. A lower dose of CuS-BSA NPs (600 μg/kg) could effectively inhibit tumor growth in H22 hepatoma-bearing mice at 980 nm NIR. Moreover, under the near-infrared laser irradiation, both in the tail vein injection group and the intratumoral injection group, a large area of necrosis in the tumor tissue, as well as the up-regulation of apoptotic proteins including cleaved caspase-3 and cleaved caspase-9 were observed. CuS-BSA NPs are promising photothermal agents in the photothermal therapy of cancer.

Targeted CuS nanoparticles and near-infrared laser irradiation for photothermal ablation therapy of KB cervical tumor xenograft

Theranostic CuS Nanoparticles Targeting Folate Receptors for PET/CT Image-Guided Photothermal Ablation Therap

Theranostic Cus Nanoparticles Targeting Folate Receptors For Pet Image-Guided Photothermal Therapy

Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells.

Photothermal effects of CuS-BSA nanoparticles on H22 hepatoma-bearing mice

Integrin αvβ3-Targeted [ 64 Cu]CuS Nanoparticles for PET/CT Imaging and Photothermal Ablation Therapy.

Cetuximab-modified CuS Nanoparticles Integrating Near-Infrared-ii-responsive Photothermal Therapy and Anti-Vessel Treatment.

A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy.

Theranostic probe for simultaneous in vivo photoacoustic imaging and confined photothermolysis by pulsed laser at 1064 nm in 4T1 breast cancer model.

Multifunctional Nanoparticles Encapsulating Astragalus Polysaccharide and Gold Nanorods in Combination with Focused Ultrasound for the Treatment of Breast Cancer

Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles

Cascade targeting tumor mitochondria with CuS nanoparticles for enhanced photothermal therapy in the second near-infrared window

Photothermal therapy of xenografted tumor by carbon nanoparticles-Fe(II) complex

Multifunctional Theragnostic Ultrasmall Gold Nanodots-Encapsuled Perfluorocarbon Nanodroplets for Laser-Focused Ultrasound Sequence Irradiation (LFSI)-Based Enhanced Tumor Ablation

Multifunctional Theragnostic Ultrasmall Gold Nanodot-Encapsuled Perfluorocarbon Nanodroplets for Laser-Focused Ultrasound Sequence Irradiation (Lfsi)-Based Enhanced Tumor Ablation.

Precision Nanomedicine Using Dual PET and MR Temperature Imaging-Guided Photothermal Therapy.

Copper Phosphide Nanoparticles Used for Combined Photothermal and Photodynamic Tumor Therapy

Degradable Hybrid CuS Nanoparticles for Imaging-Guided Synergistic Cancer Therapy Via Low-Power NIR-II Light Excitation

Cu-Chelated polydopamine nanoparticles as a photothermal medium and "immunogenic cell death" inducer for combined tumor therapy.

Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer

Fabrication of Anisotropic Cu Ferrite-Polymer Core-Shell Nanoparticles for Photodynamic Ablation of Cervical Cancer Cells